GlobeNewswire Inc.··Newamsterdam Pharma Company N.V.NewAmsterdam Pharma Gears Up for Major Healthcare Conferences Amid CETP Drug Approvals
NewAmsterdam Pharma to present at major June 2026 investor conferences ahead of expected EMA, UK, and Swiss regulatory decisions on cardiovascular drug obicetrapib.
NAMSNAMSWPhase 3 trialsinvestor conference